The Fiscal Year 2005 (FY05) Appropriation Bill was signed by President Bush on August 5, 2004. This program announcement is being released prior to the receipt of funds appropriated in the bill for this research program; funding of proposals received in response to this program announcement is contingent on the receipt of funds at the United States Army Medical Research and Materiel Command (USAMRMC).
The United States Army Medical Research and Materiel Command (USAMRMC), Office of the Congressionally Directed Medical Research Programs (CDMRP) invites applications for funding for the FY05 Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award.
The overall goal of the FY05 NFRP is to develop effective therapies for NF1, NF2, and Schwannomatosis. Within this context, support for the training of NF researchers, the encouragement of established scientists in the field, and the attraction of new scientific expertise from other fields are essential to the NF community. Proposals to the NFRP are sought across all areas of laboratory, clinical, behavioral, and epidemiological research including all disciplines within the basic, clinical, psychosocial, behavioral, sociocultural, and environmental sciences; nursing; occupational health; alternative therapies; public health and policy; and economics. Additionally, proposals that address the needs of minority, low-income, rural, and other underrepresented and/or medically underserved populations may be submitted from any eligible institutional source. Proposals are encouraged from investigators working at Historically Black Colleges and Universities/Minority Institutions (HBCU/MI). The intent of Investigator-Initiated Research Awards is to sponsor basic and clinically oriented research that will (1) provide insight into the molecular mechanisms underlying the development of neurofibromatosis (NF) and related diseases; (2) result in substantial improvement(s) over todays approach to the diagnosis and treatment of NF1, NF2, and/or Schwannomatosis; and (3) enhance the quality of life for persons with the disease(s).
Funding for Investigator-Initiated Research Awards can be requested for a maximum of $2M over a 4-year performance period, inclusive of both direct and indirect costs. Funding for Nested Postdoctoral Traineeships can be requested for a maximum of $60,000 per year inclusive of both direct and indirect costs for a maximum of $240,000 per trainee for up to a 4-year performance period. Approximately $5 million (M) is available to fund the FY05 NFRP Investigator-Initiated Research Awards. Depending on the number and quality of the applications, it is anticipated that two to three proposals will be funded.
Electronic submission is required. Proposals must be approved on the CDMRP eReceipt system by the Contract Representative at the applicants institutions Sponsored Programs Office (or equivalent) by the deadline. If your proposal is either incomplete or not approved electronically before the deadline, it will not be considered for review. No paper copy submissions will be accepted. The CDMRP uses a two-tier review process for proposals: scientific peer review, followed by programmatic review. Details of both tiers of review can be found in the Full Text of Program Announcement.
Estimated timelines for the FY05 Investigator-Initiated Research Awards are as follows: Full Proposal Submission Deadline: February 22, 2005, 5:00 p.m. Eastern Time; Peer Review: April, 2005; Programmatic Review: July, 2005; Award Start Date: Between September, 2005 and January, 2006.
For additional information or questions, please contact: Patricia A. Evans, Contracting/Grants Office, U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, phone: (301) 619-7354, Fax: (301) 619-6662, email: email@example.com
Who can apply:
Eligible functional categories:
Military Medical Research and Development
FY05 Neurofibromatosis Research Program (NFRP) Announcements
If you have problems accessing the full announcement, please contact:
US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014